25 of the Best Oncologists Near Me

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Pancreaticoduodenectomy. Dr. Lipson is board certified in American Board Of Internal Medicine.

Alex Adjei is an Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 49 years. Dr. Adjei is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Adjei is board certified in American Board Of Internal Medicine, 1995.

David Loeb, MD, PhD, is Chief, Pediatric Hematology, Oncology and Cellular Therapy at Children’s Hospital at Montefiore and Professor, Pediatrics and Professor, Developmental and Molecular Biology at Montefiore Einstein. His clinical work focuses on tumors of connective tissue, such as bone and muscle. He also has expertise in the care of children with other solid tumors. As a member of the bone marrow transplantation team, Dr. Loeb also cares for patients with acute leukemias and has expertise in the application of immunotherapy to childhood cancer. Dr. Loeb is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Bone Tumor.

Arvin K. George, MD, is a urologic surgeon specializing in the diagnosis and management of genitourinary cancers, with particular sub-specialization in kidney and prostate cancers. His clinical interests and expertise are in image-guided therapeutics, and minimally-invasive ablative/surgical techniques for prostate and kidney cancer. These include laparoscopic and robotic surgery, in addition to cryoablation, high-intensity focused ultrasound ablation, nanoparticle directed laser ablation, laser interstitial thermal therapy, and bipolar radiofrequency ablation. Dr. George obtained his medical degree from the Royal College of Surgeons in Ireland, followed by a urology residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He remained to complete his endourology/minimally-invasive and robotic surgery fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a urologic oncology fellowship at the National Cancer Institute, National Institutes of Health. He then joined the clinical facility at the University of Michigan, Ann Arbor, where he directed the Prostate Cancer Programs from 2019 through 2023. Dr. George participates extensively in the discovery of urologic science and evaluation of urologic care and has co-authored over 80 peer reviewed publications. Additionally, he has authored 11 chapters in medical education books. Dr. George sees patients in clinic throughout the Baltimore region and also is available for virtual appointments for patients in Maryland, Washington D.C., New York and Michigan. Dr. George is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. George is board certified in American Board Of Urology.

Lynn Schuchter is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Schuchter is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Melanoma, Melanoma of the Eye, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schuchter is board certified in Medical Oncology, 1989 and Internal Medicine, 1985. Dr. Schuchter is currently accepting new patients.

Saar Gill is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Gill is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gill is currently accepting new patients.

Dr. BonDurant is a multiple-time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. BonDurant believes what makes a great physician is not only skill, but the ability to genuinely care about patients. To be this type of physician every day, she strives to provide innovative quality medicine with sincere appreciation, compassion and respect for her patients. It's her privilege to care for such strong and courageous women during difficult times in their lives. Dr. Bondurant is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Cancer, Endometrial Cancer, Oophorectomy, and Hernia Surgery. Dr. Bondurant is board certified in American Board Of Obstetrics And Gynecology. Dr. Bondurant is currently accepting new patients.

Addie Alkhas is an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Alkhas is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, Bladder Reconstruction, and Oophorectomy. Dr. Alkhas is board certified in American Board Of Obstetrics & Gynecology.

Elizabeth Pelkofski is an Oncologist practicing medicine in Cooperstown, New York. Dr. Pelkofski is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Bladder Reconstruction. Dr. Pelkofski is board certified in American Board Of Obstetrics And Gynecology (Obstetrics & Gynecology, Gynecologic Oncology).

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Mayer is board certified in Medical Oncology.

Dr. Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish. His research is focused on understanding cancers utilizing sequencing technologies. He has an excellent understanding of the latest advances in thoracic oncology (lung cancer, thymic malignancies, mesothelioma). He believes in providing the same level of care for his patients that he expects for his own family. His list of peer-reviewed scientific publications can be accessed here https://pubmed.ncbi.nlm.nih.gov/?term=Devarakonda+S&cauthor_id=34591593. Dr. Devarakonda is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Devarakonda is board certified in American Board Of Internal Medicine. Dr. Devarakonda is currently accepting new patients.

Shayna Sarosiek is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Sarosiek is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Waldenstrom Macroglobulinemia, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Sarosiek is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Denmeade is board certified in American Board Of Internal Medicine.

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics. Dr. Le is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer. Dr. Le is board certified in American Board Of Internal Medicine.

Dr. Kristen Marrone is a thoracic medical oncology specialist in Baltimore, caring for patients with lung cancer and esophageal cancer. She is the Program Director of the Hematology/Medical Oncology Fellowship Program at the Johns Hopkins School of Medicine. Dr. Marrone received her undergraduate degree in psychology with a neuroscience concentration from Pennsylvania State University. She earned her M.D. from Drexel University College of Medicine. She completed her residency at Yale-New Haven Hospital and performed a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. Marrone joined the Johns Hopkins faculty in 2017. Her research interests include clinical trial development and translational studies focusing on optimization of immunotherapy in oncogene driven non-small cell lung cancer. Dr. Marrone is a member of the American Association of Cancer Research, the American Society of Clinical Oncology, the International Association for Study of Lung Cancer and the Society for Immunotherapy in Cancer. Dr. Marrone is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Marrone is board certified in American Board Of Internal Medicine.

Ernst Lengyel is an Obstetrics and Gynecologist practicing medicine in Chicago, Illinois. Dr. Lengyel is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Sertoli-Leydig Cell Tumor, Endometrial Cancer, Oophorectomy, and Splenectomy. Dr. Lengyel is board certified in Gynecologic Oncology and Practicing Since1992.

Joan Tymon is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Tymon is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tymon is board certified in American Board Of Obstetrics & Gynecology.

Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in cell extrinsic drug resistance and persistence of minimal residual disease. He has distinguished himself as an outstanding laboratory-based investigator and a superior clinician. His research has translational potential in stem cell therapeutics, as well as acute leukemia and multiple myeloma. Dr. Ghiaur is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ghiaur is board certified in American Board Of Internal Medicine.

Dr. Jimenez Jimenez, who joined the Division of Transplantation and Cell Therapy in 2016, leads Sylvesters Mismatched Allogeneic Transplant Program. His clinical and research work is dedicated to improving access to Hematopoietic Cell Transplantation (HCT) for ethnically diverse patients who lack suitable donors. A national leader in mismatched HCT, Dr. Jimenez chairs multiple trials and played a key role in establishing Sylvesters program. He also focuses on strategies to reduce relapse risk in patients with acute leukemias and myeloid neoplasms post-transplant. Dr. Jimenez is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Graft. Dr. Jimenez is currently accepting new patients.

Denise Pereira is a Hematologist Oncology specialist and a Transplant Surgeon practicing medicine in Plantation, Florida. Dr. Pereira is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Transplant. Dr. Pereira is currently accepting new patients.

Riaz Elahi is a Hematologist and an Oncologist practicing medicine in Oak Lawn, Illinois. He has been practicing medicine for over 44 years. Dr. Elahi is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Elahi is board certified in American Board Of Internal Medicine, Hematology.

Originally from Ohio, Dr. Jahangiri earned her medical degree and completed both her internship and residency at Northeast Ohio Medical University College of Medicine in Rootstown, Ohio. She went on to complete a fellowship in hematology and oncology at the University of Rochester Medical Center in Rochester, New York. Dr. Jahangiri has been practicing medicine for 6 years. Her clinical interests include gastrointestinal cancers, blood disorders and blood cancers.“I believe strongly in providing high quality oncology care for patients on the Western Slope. Cancer is so scary, and I want to help patients understand their diagnosis and options so that they can decide the best path for them. My job is to serve as a guide and support through that process.”When not working, Dr. Jahangiri enjoys running, a good book and Broadway shows. Often, she can be found partaking in one of Colorado’s many outdoor activities with her husband, three children and shelter dog. Dr. Jahangiri is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Porphyria Cutanea Tarda, Lynch Syndrome, and Colorectal Cancer. Dr. Jahangiri is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Jahangiri is currently accepting new patients.

Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.

Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Wolff is board certified in American Board Of Internal Medicine.